High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas

被引：0
|
作者：
Karl Bremer
机构：
[1] Klinik für Hämatologie und Onkologie,
[2] Augusta-Kranken-Anstalt,undefined
[3] Bergstrasse 26,undefined
[4] 44791 Bochum,undefined
[5] Germany,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2002年 / 128卷
关键词：
Bendamustine Non-Hodgkin's-lymphoma Multiple myeloma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：603 / 609
页数：6
相关论文
共 6 条
  • [1] High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas
    Bremer, K
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (11) : 603 - 609
  • [2] Long-Term Outcome and Prognostic Factors in Early-Stage Nodal Low-Grade Non-Hodgkin's Lymphomas Treated with Radiation Therapy
    Eich, Hans Theodor
    Heimann, Martina
    Stuetzer, Hartmut
    Kriz, Jan
    Reiser, Marcel
    Mueller, Rolf-Peter
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (05) : 288 - 295
  • [3] Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: Long-term results for 96 patients with tumors >5 cm
    Munck, JN
    Dhermain, F
    Koscielny, S
    Girinsky, T
    Carde, P
    Bosq, J
    Decaudin, D
    Julieron, M
    Cosset, JM
    Hayat, M
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (09) : 925 - 931
  • [4] Prognostic value of FDG PET and computed tomography (CT) after 3 and 6 cycles of chemotherapy in patients treated by additional high-dose chemotherapy for high-grade non-Hodgkin's-lymphoma (NHL)
    Cremerius, U
    Fabry, U
    Wildberger, J
    Zimny, M
    Nowak, B
    Reinartz, P
    Setani, K
    Schaefer, W
    Guenther, RW
    Osieka, R
    Buell, U
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1084 - 1084
  • [5] Long-Term Outcome and Prognostic Factors in Early-Stage Nodal Low-Grade Non-Hodgkin’s Lymphomas Treated with Radiation TherapyBehandlungsergebnisse und prognostische Faktoren nach Radiotherapie niedrigmaligner nodaler Non-Hodgkin-Lymphome in frühen Stadien
    Hans Theodor Eich
    Martina Heimann
    Hartmut Stützer
    Jan Kriz
    Marcel Reiser
    Rolf-Peter Müller
    [J]. Strahlentherapie und Onkologie, 2009, 185 (5) : 288 - 295
  • [6] Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation
    Kaya, H
    Keung, YK
    Case, D
    Cruz, JM
    Perry, JJ
    Radford, JE
    Hurd, DD
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (10) : 544 - 549
1